Quality of Life and Device Acceptance in Patients With ICD Undergoing Remote ICD FU

NCT ID: NCT02888028

Last Updated: 2018-06-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

182 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-05-31

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study investigates whether an additional remote follow-up of patients with implantable cardioverter-defibrillators (ICDs) has beneficial effects on Quality of life (QoL), levels of anxiety and depression and device acceptance. Patients are randomized to either conventional in-office FU only or additional remote surveillance, follow-up duration is 12 months. The influence of other variables (age, sex,..) is evaluated regarding their influence on study endpoints.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The rising number of implantable cardiac devices leads to an increasing amount of device-related workload, e.g. regular in-office follow-ups (FU). New means of ICD FU strategies are necessary to handle the increasing burden. ICD remote monitoring promises a time- and cost efficient alternative to conventional in-office FU strategies. Many studies have already shown benefits on FU burden reduction, on saving of costs and time, and recently on total mortality. The impact of remote ICD FU on Quality of life, anxiety and depression levels and device acceptance is still under discussion. The aim of this trial is to investigate the influence of additional remote ICD surveillance on the primary endpoint health related quality of life (HRQoL), further on levels of anxiety and depression and on device acceptance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Anxiety Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ICD remote monitoring

Active Comparator: ICD remote monitoring additionally to regular in-office visits/FU 1,3,6 and 12 months post implantation of an ICD or post ICD replacement

Group Type ACTIVE_COMPARATOR

ICD remote monitoring

Intervention Type PROCEDURE

ICD remote monitoring additionally to regular in-office visits

Control group

Regular in-office visits/FU 1,3,6 and 12 months post implantation of an ICD or post ICD replacement w/o remote FU

Group Type OTHER

Control group

Intervention Type OTHER

Regular in-office visits/FU 1,3,6 and 12 months post implantation of an ICD or post ICD replacement w/o remote FU

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ICD remote monitoring

ICD remote monitoring additionally to regular in-office visits

Intervention Type PROCEDURE

Control group

Regular in-office visits/FU 1,3,6 and 12 months post implantation of an ICD or post ICD replacement w/o remote FU

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients willing to participate
* Patients with new-implantation of an ICD or device replacement due to battery depletion between May 2011 and April 2013
* Sufficient knowledge of the German language
* Expectancy of life \>1 years at good clinical status
* Written informed consent

Exclusion Criteria

* Age \<18 years
* Subjects not able to give written informed consent
* Subjects without sufficient German language skills
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Klinikum Bielefeld

OTHER

Sponsor Role collaborator

LMU Klinikum

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Johannes Siebermair, MD

Johannes Siebermair, MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Johannes Siebermair, MD

Role: PRINCIPAL_INVESTIGATOR

Munich University Clinic, Campus Grosshadern, Munich, Germany

Florian Leppert, MSc

Role: PRINCIPAL_INVESTIGATOR

Bielefeld University, School of public health Bielefeld, Germany

Stefan Kääb, MD

Role: PRINCIPAL_INVESTIGATOR

Munich University Clinic, Campus Grosshadern, Munich, Germany

Wolfgang Greiner, MD

Role: PRINCIPAL_INVESTIGATOR

Bielefeld University, School of public health, Bielefeld, Germany

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Bielefeld University, School of public health

Bielefeld, , Germany

Site Status

Munich University Clinic, Campus Grosshadern

Munich, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GE IDE MucM001-11

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

In-depth Interviews of Patients With ICDs
NCT07258602 ENROLLING_BY_INVITATION